ZA200802084B - Particulate lipid pharmaceutical composition - Google Patents

Particulate lipid pharmaceutical composition

Info

Publication number
ZA200802084B
ZA200802084B ZA200802084A ZA200802084A ZA200802084B ZA 200802084 B ZA200802084 B ZA 200802084B ZA 200802084 A ZA200802084 A ZA 200802084A ZA 200802084 A ZA200802084 A ZA 200802084A ZA 200802084 B ZA200802084 B ZA 200802084B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical composition
lipid pharmaceutical
particulate lipid
particulate
composition
Prior art date
Application number
ZA200802084A
Other languages
English (en)
Inventor
Hersloef Bengt
Kornfeldt Anna
Tingvall Per
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Publication of ZA200802084B publication Critical patent/ZA200802084B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200802084A 2005-09-16 2008-03-05 Particulate lipid pharmaceutical composition ZA200802084B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0502043 2005-09-16

Publications (1)

Publication Number Publication Date
ZA200802084B true ZA200802084B (en) 2009-08-26

Family

ID=37865220

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200802084A ZA200802084B (en) 2005-09-16 2008-03-05 Particulate lipid pharmaceutical composition

Country Status (14)

Country Link
US (1) US20080260816A1 (fr)
EP (1) EP1933876A1 (fr)
JP (1) JP2009508855A (fr)
KR (1) KR20080043845A (fr)
CN (1) CN101365491A (fr)
AU (1) AU2006291588A1 (fr)
BR (1) BRPI0616076A2 (fr)
CA (1) CA2620299A1 (fr)
EA (1) EA012422B1 (fr)
IL (1) IL189855A0 (fr)
MX (1) MX2008003644A (fr)
SG (1) SG140723A1 (fr)
WO (1) WO2007032727A1 (fr)
ZA (1) ZA200802084B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8444967B2 (en) * 2010-07-09 2013-05-21 Master Supplements, Inc. Treatment including prebiotic composition for use with probiotics
DE102007056424A1 (de) * 2007-11-23 2009-05-28 Neopharmacie Gmbh Pharmazeutische Zusammensetzung, enthaltend eine Öl/Wasser-Emulsion
KR101423674B1 (ko) * 2013-08-22 2014-08-01 (주)약침학회 유지류 또는 지용성 성분을 포함하는 약침용 조성물의 조제 또는 제조방법, 및 이로부터 조제된 약침용 조성물
US10668041B2 (en) 2014-12-08 2020-06-02 Societe Des Produits Nestle Sa Compositions and methods comprising medium chain triglycerides for treatment of epilepsy
AU2015358958B2 (en) * 2014-12-08 2020-10-01 Société des Produits Nestlé S.A. Compositions and methods comprising medium chain triglycerides for treatment of epilepsy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2158084T3 (es) * 1994-02-04 2001-09-01 Lipocore Holding Ab Preparaciones vehiculo lipofilicas.
US5672358A (en) * 1994-06-21 1997-09-30 Ascent Pharmaceuticals, Inc. Controlled release aqueous emulsion
JP3515296B2 (ja) * 1996-10-28 2004-04-05 横浜ゴム株式会社 重荷重用空気入りタイヤ
US5891476A (en) * 1997-12-22 1999-04-06 Reo; Joe P. Tastemasked pharmaceutical system
SE9800729L (sv) * 1998-03-06 1999-09-07 Scotia Lipidteknik Ab Ny topikal formulering I
ITMI20021392A1 (it) * 2002-06-25 2003-12-29 Nicox Sa Forme farmaceutiche per la somministrazione orale di farmaci liquidi a temperatura ambiente dotate di migliore biodisponibilita'
ES2385397T5 (es) * 2005-03-04 2015-08-10 Dsm Ip Assets B.V. Composición lipídica en partículas para productos alimenticios

Also Published As

Publication number Publication date
SG140723A1 (en) 2008-04-28
MX2008003644A (en) 2008-04-30
EA012422B1 (ru) 2009-10-30
CN101365491A (zh) 2009-02-11
IL189855A0 (en) 2008-08-07
AU2006291588A1 (en) 2007-03-22
EP1933876A1 (fr) 2008-06-25
CA2620299A1 (fr) 2007-03-22
WO2007032727A1 (fr) 2007-03-22
BRPI0616076A2 (pt) 2011-06-07
KR20080043845A (ko) 2008-05-19
US20080260816A1 (en) 2008-10-23
EA200800833A1 (ru) 2008-08-29
JP2009508855A (ja) 2009-03-05

Similar Documents

Publication Publication Date Title
HK1244267A1 (zh) 包含(r)-n-甲基納曲酮的藥物組合物
IL177480A0 (en) Pharmaceutical composition
IL186336A0 (en) Pharmaceutical composition
IL188352A0 (en) Pharmaceutical compositions
IL187748A0 (en) Pharmaceutical compositions containing misoprostal
ZA200804103B (en) Pharmaceutical compositions
EP1937255A4 (fr) Composition pharmaceutique
EP1862184A4 (fr) Composition pharmaceutique
GB0522045D0 (en) Pharmaceutical compositions
IL192091A0 (en) Pharmaceutical compositions
MX2008003644A (en) Particulate lipid pharmaceutical composition
EP1889613A4 (fr) Composition pharmaceutique comprenant de la vitamine k
HU0401177D0 (en) Pharmaceutical composition
GB2411355B (en) Pharmaceutical composition
EP1845944A4 (fr) Compositions pharmaceutiques
ZA200701932B (en) Pharmaceutical composition
GB0425255D0 (en) Pharmaceutical composition
ZA200701931B (en) Pharmaceutical composition
GB0512246D0 (en) Novel pharmaceutical
ZA200803566B (en) Pharmaceutical compositions
EP1864664A4 (fr) Preparation pharmaceutique
GB0514259D0 (en) Pharmaceutical compositions
HUP0401176A2 (en) Pharmaceutical composition having prpkinetic effect
GB0517043D0 (en) Improvements in pharmaceutical compositions
GB0402799D0 (en) Pharmaceutical composition